SCHEMBL21240892

SCHEMBL21240892

CCCC(C)c1ccc2c(c1)c(C)nn2C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 3/20 0.46
▸ ADORA2B P29275 3/20 0.46
▸ LSS P48449 1/20 0.36
▸ GRM4 Q14833 1/20 0.34
▸ MCHR1 Q99705 1/20 0.34
▸ QPCT Q16769 1/20 0.33
▸ RORA P35398 1/20 0.33
▸ RORC P51449 1/20 0.33
▸ RORB Q92753 1/20 0.33
▸ BRD4 O60885 2/20 0.32
▸ PSEN1 P49768 1/20 0.32
▸ PSEN2 P49810 1/20 0.32
▸ APH1B Q8WW43 1/20 0.32
▸ NCSTN Q92542 1/20 0.32
▸ APH1A Q96BI3 1/20 0.32
▸ PSENEN Q9NZ42 1/20 0.32
▸ CHRM4 P08173 1/20 0.32
▸ CACNA1H O95180 1/20 0.32
▸ PIM1 P11309 2/20 0.32
▸ MAPK8 P45983 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21239907 1.00 ADORA2A (0.46) ADORA2AADORA2BLSSGRM4MCHR1
SCHEMBL13394505 0.81 ADORA2A (0.55) ADORA2AADORA2BLSSGRM4MCHR1
SCHEMBL18713682 0.80 ADORA2A (0.50) ADORA2AADORA2BLSSGRM4MCHR1
SCHEMBL24759258 0.78 ADORA2A (0.52) ADORA2AADORA2BLSSGRM4MCHR1
SCHEMBL19441842 0.78 ADORA2A (0.52) ADORA2AADORA2BLSSGRM4MCHR1
SCHEMBL24759259 0.78 ADORA2A (0.52) ADORA2AADORA2BLSSGRM4MCHR1
SCHEMBL19003532 0.78 ADORA2A (0.41) ADORA2AADORA2BLSSGRM4MCHR1
SCHEMBL23135082 0.77 KEAP1 (0.35) ADORA2AADORA2BGRM4
SCHEMBL19236877 0.75 KEAP1 (0.49) —
SCHEMBL26740887 0.72 ADORA2A (0.52) ADORA2AADORA2BLSSGRM4MCHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2968316-B1 2-HYDROXY-1-{4-[(4-PHENYLPHENYL)CARBONYL]PIPERAZIN-1-YL}ETHAN-1-ONE DERIVATIVES AND RELATED COMPOUNDS AS FATTY ACID SYNTHASE (FASN) INHIBITORS FOR THE TREATMENT OF CANCER FORMA THERAPEUTICS INC (US) 2019-08-07 — — EP disclosed
Send feedback